PubRank

Jakub Tolar

Author PubWeight™ 86.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood 2010 3.39
2 Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010 2.82
3 Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006 2.10
4 Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. Blood 2011 2.03
5 Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 2011 2.01
6 Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning. Blood 2013 1.91
7 TALEN-based gene correction for epidermolysis bullosa. Mol Ther 2013 1.84
8 The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci U S A 2010 1.82
9 Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia. Blood 2010 1.77
10 Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood 2004 1.67
11 Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006 1.58
12 Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies. Mol Ther 2008 1.47
13 Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system. Blood 2005 1.40
14 Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia. Blood 2009 1.35
15 A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system. Mol Ther 2005 1.23
16 Dyskeratosis congenita: the first NIH clinical research workshop. Pediatr Blood Cancer 2009 1.22
17 Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin North Am 2010 1.21
18 Hematopoietic cell therapy for metabolic disease. J Pediatr 2007 1.17
19 Transplant outcomes in leukodystrophies. Semin Hematol 2010 1.14
20 Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes. Eur J Pediatr 2011 1.13
21 Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome. Pediatr Res 2005 1.12
22 Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells. J Exp Med 2007 1.09
23 Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther 2010 1.08
24 Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita. Biol Blood Marrow Transplant 2013 1.07
25 Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD). Blood 2007 1.07
26 Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming. Blood 2009 0.98
27 Comparative evaluation of set-level techniques in predictive classification of gene expression samples. BMC Bioinformatics 2012 0.98
28 Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J Neuroinflammation 2011 0.98
29 A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity. Clin Immunol 2007 0.96
30 Stromal cell-derived factor-1 and hematopoietic cell homing in an adult zebrafish model of hematopoietic cell transplantation. Blood 2011 0.94
31 SEGS: search for enriched gene sets in microarray data. J Biomed Inform 2007 0.94
32 Adeno-associated virus-mediated delivery of a mutant endostatin in combination with carboplatin treatment inhibits orthotopic growth of ovarian cancer and improves long-term survival. Cancer Res 2006 0.94
33 Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J Invest Dermatol 2012 0.92
34 Expression of telomerase and telomere length are unaffected by either age or limb regeneration in Danio rerio. PLoS One 2009 0.91
35 Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product. Mol Ther 2008 0.91
36 Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity. PLoS One 2012 0.90
37 A biologic Velcro patch. N Engl J Med 2015 0.90
38 An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT). Mol Genet Metab 2012 0.90
39 Pericardial effusion after pediatric hematopoietic cell transplant. Pediatr Transplant 2013 0.89
40 Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa. Stem Cell Res Ther 2014 0.89
41 Granulocyte colony-stimulating factor mobilized CFU-F can be found in the peripheral blood but have limited expansion potential. Haematologica 2008 0.88
42 Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry. Clin Chem 2011 0.88
43 Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery. Mol Ther 2007 0.88
44 Osteopetrosis with micro-lacunar resorption because of defective integrin organization. Lab Invest 2009 0.87
45 Fanconi anemia gene editing by the CRISPR/Cas9 system. Hum Gene Ther 2015 0.87
46 Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick disease. Blood 2010 0.87
47 Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome. J Pediatr 2012 0.87
48 Leukotriene-receptor inhibition for the treatment of systemic mastocytosis. N Engl J Med 2004 0.86
49 Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion. Pediatr Blood Cancer 2011 0.86
50 Induction of comprehensible models for gene expression datasets by subgroup discovery methodology. J Biomed Inform 2004 0.86
51 Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration. Blood 2013 0.85
52 Synthetic zinc finger nuclease design and rapid assembly. Hum Gene Ther 2011 0.85
53 Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction. PLoS One 2012 0.85
54 Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system. Biol Blood Marrow Transplant 2008 0.85
55 Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010. Biol Blood Marrow Transplant 2010 0.83
56 Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2008 0.83
57 Skeletal muscle contractile function and neuromuscular performance in Zmpste24 -/- mice, a murine model of human progeria. Age (Dordr) 2011 0.83
58 Sleeping Beauty-mediated correction of Fanconi anemia type C. J Gene Med 2011 0.83
59 Prediction of DNA-binding propensity of proteins by the ball-histogram method using automatic template search. BMC Bioinformatics 2012 0.83
60 Bone marrow stromal and vascular smooth muscle cells have chemosensory capacity via bitter taste receptor expression. PLoS One 2013 0.82
61 Pharmacokinetics of clofarabine in patients with high-risk inherited metabolic disorders undergoing brain-sparing hematopoietic cell transplantation. J Clin Pharmacol 2010 0.82
62 Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions. Cytotherapy 2010 0.81
63 DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo. Blood 2013 0.80
64 Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation. J Clin Pharmacol 2011 0.80
65 Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT). J Clin Pharmacol 2008 0.80
66 Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cells. Cardiovasc Pathol 2010 0.80
67 Lipid composition of whole brain and cerebellum in Hurler syndrome (MPS IH) mice. Neurochem Res 2011 0.79
68 Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim. Pediatr Blood Cancer 2010 0.79
69 Prediction of DNA-binding proteins from relational features. Proteome Sci 2012 0.79
70 Hip dysplasia in patients with Hurler syndrome (mucopolysaccharidosis type 1H). J Pediatr Orthop 2013 0.78
71 sdf1 Expression reveals a source of perivascular-derived mesenchymal stem cells in zebrafish. Stem Cells 2014 0.78
72 [Variability of the deep femoral venous system]. Cas Lek Cesk 2011 0.78
73 Hematopoietic cell transplantation for hemoglobinopathies. Curr Probl Pediatr Adolesc Health Care 2008 0.77
74 Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies. Am J Physiol Heart Circ Physiol 2010 0.77
75 Zebrafish stromal cells have endothelial properties and support hematopoietic cells. Exp Hematol 2011 0.77
76 Transplacental transfer of small-cell carcinoma of the lung. N Engl J Med 2002 0.76
77 Outcome of penetrating keratoplasty for mucopolysaccharidoses. Arch Ophthalmol 2011 0.76
78 Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 2008 0.76
79 Incidence of intracranial germ cell tumors by race in the United States, 1992-2010. J Neurooncol 2014 0.76
80 Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD). Transplantation 2016 0.75
81 Case 4-2008: A pregnant woman with a swollen left breast and dyspnea. N Engl J Med 2008 0.75
82 T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction. JCI Insight 2017 0.75
83 Lactic acidosis and hypoglycemia with ALL relapse following engrafted bone marrow transplant. Pediatr Blood Cancer 2009 0.75